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12-Month prevalence of known diabetes mellitus in Germany
Abstract
Diabetes mellitus is a metabolic disease involving chronic dysfunction of blood sugar regulation; if left untreated, 
it can result in serious secondary illnesses. In 2014 and 2015, a total of 7.0% of women and 8.6% of men in Germany 
with an age of 18 and over reported having diabetes mellitus in the past 12 months (these figures do not include 
gestational diabetes). There are significant differences in the 12-month prevalence among adults: the prevalence 
of known diabetes increases significantly with age, and is particularly high among people with a low educational 
status and those living in Saxony-Anhalt or Brandenburg. The Robert Koch Institute is currently developing a diabetes 
surveillance system in order to establish a data-based fundament for guiding health policy decisions in Germany.
 DIABETES MELLITUS · PREVALENCE · HEALTH SURVEY · GERMANY · ADULTS 
Introduction
Diabetes mellitus is a metabolic disorder that involves a 
dysfunction of blood glucose regulation [1]. It can cause 
chronically elevated blood sugar concentrations, which, 
if left untreated, can damage blood vessels and nerves. 
In turn, these disorders increase the risk of concomitant 
diseases and secondary illnesses such as heart attacks, 
strokes, renal dysfunction, retinal damage and diabetic 
foot syndrome [2]. Diabetes also reduces a person’s qual-
ity of life and life expectancy [3, 4]. Further, it results in 
high direct and indirect costs to the health system due 
to the expenses incurred through diabetes care and treat-
ment as well as through the loss of resources associated 
with incapacities to work or forced early retirement [5].
The most important forms of diabetes are type 1, type 
2 and gestational diabetes [6]. Type 1 diabetes is an auto-
immune disease and mainly develops during childhood 
or adolescence. Type 2 diabetes is the most common form 
and usually affects adults over the age of 40. Alongside a 
genetic predisposition, the main risk factors linked to type 
2 diabetes are an unfavourable diet, a lack of exercise, and 
the resulting overweight. Gestational diabetes normally 
only exists during pregnancy; however, it is linked to an 
increased risk of type 2 diabetes in older age [7].
Indicator
The 12-month prevalence of diabetes mellitus for GEDA 
2014/2015–EHIS was assessed using a self-administered 
paper-based or online questionnaire. The study posed 
the question ‘During the past 12 months, have you had 
any of the following diseases or conditions?’ This ques-
tion was followed by a list of diseases that also included 
‘diabetes (not including gestational diabetes)’. Thus, the 
study excludes gestational diabetes. However, it is not 
possible to differentiate between type 1 and type 2 dia-
betes in the results.
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The present analysis is based on data provided by 
23,345 participants aged 18 and above from the GEDA 
2014/2015-EHIS study who also provided information 
about their 12-month prevalence of diabetes (671 partic-
ipants were excluded from the analysis as this data was 
lacking). The analysis was conducted using a weighting 
factor that corrects for deviations within the sample from 
the population structure for gender and age within Ger-
many’s federal states (as of 31 December 2014) as well 
as for municipality type and level of education. The arti-
cle entitled German Health Update: New data for Ger-
many and Europe [8], which is also published in this 
issue, sets out the details of the methodology employed 
for GEDA 2014/2015-EHIS. Educational status was 
defined in accordance with the International Standard 
Classification of Education (ISCED) [9]. P-values of <0.05 
were considered statistically significant.
Results and discussion
In GEDA 2014/2015-EHIS, 7.7% of participants aged 18 
or above reported the presence of a diabetes mellitus 
(not including gestational diabetes) during the last 12 
months (see Table 1). The prevalence was lower among 
women with 7.0% than among men with 8.6%.
The last telephone survey conducted by the Robert 
Koch Institute of adults aged 18 or over was undertaken 
Women % (95%-CI)
Women total 7.0 (6.4-7.6)
18–29 Years 1.1 (0.6-1.9)
Low education 2.7 (1.1-6.5)
Medium education 0.6 (0.3-1.2)
High education 0.5 (0.1-1.6)
30 – 44 Years 1.4 (0.9-2.1)
Low education 3.7 (1.7-8.1)
Medium education 1.3 (0.8-2.2)
High education 0.4 (0.2-1.0)
45 – 64 Years 5.2 (4.5-6.1)
Low education 8.5 (6.3-11.3)
Medium education 5.0 (4.0-6.1)
High education 3.1 (2.2-4.1)
≥ 65 Years 17.6 (15.9-19.6)
Low education 20.5 (17.5-23.8)
Medium education 15.6 (13.3-18.4)
High education 15.9 (11.9-20.8)
Total (women and men) 7.7 (7.3-8.2)
*N = 52 missing values for educational status; CI = confidence interval 
Men % (95%-CI)
Men total 8.6 (7.9-9.2)
18 – 29 Years 0.5 (0.2-1.0)
Low education 0.3 (0.1-1.3)
Medium education 0.6 (0.2-1.4)
High education 0.5 (0.1-3.3)
30 – 44 Years 2.0 (1.4-2.9)
Low education 2.0 (0.7-5.5)
Medium education 2.3 (1.4-3.7)
High education 1.6 (0.9-2.9)
45 – 64 Years 9.3 (8.2-10.6)
Low education 16.9 (13.0-21.7)
Medium education 9.7 (8.1-11.7)
High education 5.9 (4.8-7.3)
≥ 65 Years 21.1 (19.1-23.2)
Low education 24.0 (19.7-28.9)
Medium education 21.3 (18.4-24.5)
High education 19.5 (16.6-22.6)
Total (women and men) 7.7 (7.3-8.2)
Table 1 
12-month prevalence (95% CI) of known
diabetes (not including gestational diabetes) 




Data holder: Robert Koch Institute
Aims:  to provide reliable informa-
tion about the population’s 
health status, health-related 
behaviour and health care in 
Germany, with the possibility 
of a European comparison
Method:   questionnaires completed 
on paper or online
Population:   people aged 18 years and 
above with permanent resi-
dency in Germany
Sampling:   registry office sample; ran-
domly selected individuals 
from 301 communities in 
Germany were invited to par-
ticipate
Participants:   24,016 people (10,872 men; 
13,144 women)
Response rate:  26.9%
Study period:  November 2014 – July 2015
Data protection:  all participants were informed 
about the study’s aims and 
content and about data pro-
tection, and provided their 
informed consent
More information is available at 
www.geda-studie.de
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in 2012 (GEDA 2012). This study found a comparable 
12-month prevalence (7.7% overall) to that of GEDA
2014/2015-EHIS [10]. However, a comparison of gen-
der-specific prevalence demonstrates small deviations
in opposite directions. The 12-month prevalence derived
from the GEDA 2012 data is slightly higher among
women (7.5%) and slightly lower among men (7.9%)
than the prevalence estimated by the current GEDA
2014/2015-EHIS data [10]. These variations are probably
mostly due to the different questions posed by the stud-
ies. In GEDA 2012 respondents were asked whether they
ever had a physician-diagnosed diabetes, which sus-
tained during the preceding 12 months; this could explain
the lower prevalence. However, the question did not
exclude gestational diabetes; this could explain the
higher prevalence of diabetes only among women. Data
from the German Health Interview and Examination
Study for Adults (DEGS1, 2008-2011) provides an indi-
cation of the degree of gestational diabetes occurring
among women: the study found a prevalence of physi-
cian-diagnosed diabetes which had only occurred during
pregnancy in women between 18 and 79 years of age of
1.2%. This corresponds to 16.3% of the lifetime preva-
lence of diabetes in women [11].
With respect to changes over time, a significant 
increase in lifetime prevalence of physician-diagnosed 
diabetes in adults of 18 and above is evident from the 
telephone surveys conducted in 2003 (GSTel03) com-
pared with 2009 (GEDA 2009). During this time, the 
prevalence increased from 6.8% to 9.3% in women and 
from 5.4% to 8.2% in men [10, 12]. Similarly, a compar-
ison of the examination surveys conducted between 
1997 and 1999 (GNHIES98) and between 2008 and 
2011 (DEGS1) demonstrates a significant increase in 
the lifetime prevalence of physician-diagnosed diabe-
tes among 18- to 79-year-olds [11]. In addition, data 
from statutory health insurers also indicate an increased 
prevalence of diagnosed diabetes between 2000 and 
2010 [13-15]. In contrast, no other relevant changes in 
prevalence were observed based on the telephone sur-
veys conducted between 2009 and 2012 (GEDA 2009, 
GEDA 2010 and GEDA 2012). A slight trend towards 
an increased lifetime and 12-month prevalence was 
observed among men between 2009 and 2012; how-
ever, this trend in men was not statistically significant, 
nor was it observed in women (lifetime prevalence: 
8.2%, 8.5%, 8.7% for men, 9.3%, 8.8%, 9.0% for women 
[10]; 12-month prevalence: 7.2%, 7.6%, 7.9% for men, 
7.5%, 7.1%, 7.5% for women [10, 16, 17]).
Several factors need to be taken into account when 
interpreting these temporal developments in the preva-
lence of known diabetes. First, up to about one third of 
the increase in prevalence that occurred within the time 
period between 2000 and 2010 can be explained by pop-
ulation aging [11-13]. However, even after aging has been 
accounted for, the increase in known diabetes remains 
statistically significant [11, 12]. Second, the increase could 
also partially be explained by earlier diabetes diagnosis 
resulting from a stronger focus on diabetes among med-
ical staff (such as since the introduction of the Disease 
Management Program for type 2 diabetes) [18]) or 
changes to diagnostic criteria [19, 20]. This would cause 
the proportion of diagnosed cases to rise, and the share 
of undetected cases to fall. The recently observed 
7.7% of adults in Germany 
(7.0% of women and 8.6% of 
men) reported having  
diabetes mellitus (not inclu-
ding gestational diabetes)  
in the last 12 months.
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decrease in the prevalence of undiagnosed diabetes sug-
gests that improvements may have resulted in an earlier 
detection of diabetes [21]. Third, improved care for peo-
ple with diabetes (such as since the introduction of the 
Disease Management Program [18] and the module for 
the German National Disease Management Guideline 
(NDMG) on type 2 diabetes [22]) and the associated 
longer survival could also contribute to the increased 
prevalence of diagnosed diabetes. The increased pro-
portions of 45- to 79-year-olds who are affected by dia-
Fig. 1 
12-month prevalence of known diabetes
(not including gestational diabetes) in women 
and men according to German federal state 
(N=23,345) 
Source: GEDA 2014/2015-EHIS
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Men and women in  
Saxony-Anhalt and Branden-
burg have a significantly  
higher 12-month prevalence  
of known diabetes compared 
to the average prevalence  
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betes but who have achieved their therapy goal with 
regard to the laboratory parameter HbA1c, who self-mon-
itor their blood-glucose level or who have had annual 
eye and foot examination suggest that diabetes care has 
at least partly improved [23]. Finally, the temporal devel-
opments in behavioural risk factors continue to play a 
role in the dynamics of diabetes prevalence. However, 
diverging temporal trends have been observed for sin-
gle risk factors what complicates the evaluation of 
changes in the overall diabetes risk. For example, the 
prevalence of physical inactivity decreased, whereas the 
prevalence of obesity increased [24, 25].
Analyses of the GEDA 2014/2015-EHIS data stratified 
according to age and level of education reveal significant 
differences in the 12-month prevalence of known dia-
betes among the adult population in Germany. The 
12-month prevalence for men and women under 45 is
no more than 2.0%; however, the prevalence rises
strongly with age to 5.2% among women and 9.3%
among men of 45 to 64 years of age, and to 17.6% among
women and 21.1% among men of 65 and above. More-
over, men and women with a lower level of education
are more likely to have known diabetes than those with
a higher level of education. Whereas this difference is
pronounced among women of all ages, it does not occur
among men until the 45-to-64 age group (see Table 1).
Similarly, a significantly higher prevalence of undetected
diabetes was also observed with increasing age and lower
educational status [21, 26].
Compared to the average 12-month prevalence of 
known diabetes over all federal states, significantly higher 
prevalence estimates were observed among women in 
Saxony-Anhalt, Brandenburg, Thuringia and Saarland, 
and among men in Saxony-Anhalt, Brandenburg and 
Rhineland-Palatinate (see Figure 1). In contrast, women 
in Bremen, Schleswig-Holstein, Hessen, Baden-Würt-
temberg and Bavaria, and men in Hamburg and 
Baden-Württemberg have significantly lower prevalence 
estimates compared to the national average. Even after 
the differences in age structure and educational status 
between the German federal states have been taken into 
account, most of the deviations from the national aver-
age remain (with the exception of men in Rhineland-Pa-
latinate, Hamburg and Baden-Württemberg). Similar 
regional patterns were identified for the prevalence of 
physician-diagnosed diabetes by a pooled analysis of 
GEDA data from 2009, 2010 and 2012 and for the preva-
lence of diagnosed type 2 diabetes in an analysis of AOK 
health insurance data from 2010 [27, 28]. Nevertheless, 
it is important to remember that the prevalence of known 
diabetes may also differ considerably within a federal 
state [14, 29]. The comparison of EHIS data at the Euro-
pean level that was undertaken for the OECD/EU report 
'Health at a Glance: Europe 2016' as well as for the arti-
cle Health monitoring and health indicators in Europe 
that is also published in this issue shows that the 
12-month prevalence of known diabetes in Germany is
similar to the European average [30, 31]. When interpret-
ing the different prevalence levels of known diabetes
within Germany and Europe, alongside differences in
age structure, differences in factors mentioned above
such as the relation of diagnosed cases to undetected
cases, the diabetes care situation, and risk factor load
again need to be taken into account.




age among both men and
women.
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In summary, diabetes mellitus is a frequent disease 
among the adult German population with a particular 
high prevalence among women and men with an age of 
45 or above, with a lower level of education, and from 
Saxony-Anhalt and Brandenburg. These population 
groups need to be more strongly targeted by measures 
aimed at prevention, early detection and care. The 
Robert Koch Institute is developing a diabetes surveil-
lance system in order to establish a sustainable diabetes 
reporting and a data-driven basis for guiding health-pol-
icy decisions in Germany. This includes the definition of 
suitable indicators for tracking the risk factors and the 
burden associated with diabetes as well as the identifi-
cation of existing barriers to data usage and of data gaps. 
Concept and current status of the diabetes surveillance 
system are described in detail in a Concepts & Methods 
article published in this issue [32].
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